Does LEUPROLIDE Cause Metastasis? 201 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 201 reports of Metastasis have been filed in association with LEUPROLIDE (Fensolvi). This represents 0.3% of all adverse event reports for LEUPROLIDE.
201
Reports of Metastasis with LEUPROLIDE
0.3%
of all LEUPROLIDE reports
42
Deaths
49
Hospitalizations
How Dangerous Is Metastasis From LEUPROLIDE?
Of the 201 reports, 42 (20.9%) resulted in death, 49 (24.4%) required hospitalization, and 4 (2.0%) were considered life-threatening.
Is Metastasis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEUPROLIDE. However, 201 reports have been filed with the FAERS database.
What Other Side Effects Does LEUPROLIDE Cause?
Hot flush (9,146)
Death (8,772)
Intercepted product preparation error (8,621)
Syringe issue (7,847)
Device leakage (5,861)
Wrong technique in product usage process (5,062)
Fatigue (4,805)
Injection site pain (4,678)
Prostatic specific antigen increased (2,432)
Asthenia (2,176)
What Other Drugs Cause Metastasis?
RIBOCICLIB (404)
LETROZOLE (284)
TRASTUZUMAB (273)
CYCLOPHOSPHAMIDE (267)
FULVESTRANT (262)
CAPECITABINE (233)
BEVACIZUMAB (225)
CARBOPLATIN (206)
PACLITAXEL (198)
RITUXIMAB (191)
Which LEUPROLIDE Alternatives Have Lower Metastasis Risk?
LEUPROLIDE vs LEVALBUTEROL
LEUPROLIDE vs LEVAMISOLE
LEUPROLIDE vs LEVAQUIN
LEUPROLIDE vs LEVEMIR
LEUPROLIDE vs LEVETIRACETAM